longbridge

Alzamend Neuro

ALZN
----

All Shareholders

Shareholder Type

  • Public and others72.77%
  • Institutions26.86%
  • Private companies0.36%
  • Individuals & Insiders0.02%
  • Public companies0.00%

Major Shareholders

Major Shareholders Latest
Shareholder
Kingsbury Capital Investment Advisors LLC
23.21%1.12M8.02%-209.17K
Ault Lending, LLC
2.42%116.65K0.32%+0
Vanguard Capital Management, LLC
0.59%28.58K0.08%+3.16K
Geode Capital Management, LLC
0.55%26.37K0.65%-19.31K
Ault Life Sciences, Inc.
0.23%11.07K0.03%+0
Tower Research Capital Europe Limited
0.07%3.52K0.09%-2.67K
UBS Asset Management AG
0.05%2.35K0.07%-2.15K
David KatzoffChief Financial Officer
0.01%615.00<0.01%+0
BlackRock, Inc.
<0.01%437.00<0.01%+0
Jeffrey OramIndependent Director
<0.01%74.00<0.01%+0
Ault & Company, Inc.
<0.01%61.00<0.01%+0
Stephan JackmanCEO & Director
<0.01%50.00<0.01%+17.00
Mark GustafsonIndependent Director
<0.01%44.00<0.01%+0
IFG Advisory, LLC
<0.01%22.00--+22.00
SBI Holdings, Inc.
<0.01%22.00<0.01%+0
Caitong International Asset Management Co., Limited
<0.01%3.00<0.01%-1.00
Harbor Investment Advisory, LLC
<0.01%1.000.00%+0
Lynne McGrathFormer Independent Director
0.00%0.00<0.01%-25.00
William HorneIndependent Chairman of Board
0.00%0.000.00%+0
Kenneth CragunSenior Vice President of Finance
0.00%0.000.00%+0
© 2026 Longbridge｜Terms of ServicePrivacy Policy